Differences in coverage among these racial and ethnic groups compared with that in White adults peaked during March–May 2021, after which disparities began to diminish (Figure). adults were eligible to receive COVID-19 vaccine, vaccination coverage was highest among adults who were Asian (69.6%) or White (59.0%), and lower among those who were Hispanic (47.3%), Black (46.3%), NH/OPI (45.9%), multiple or other race (42.6%), or AI/AN (38.7%) ( Figure). This activity was reviewed by CDC and was conducted consistent with applicable federal law and CDC policy.***īy the end of April 2021, when all U.S. Analyses were conducted using SAS (version 9.4 SAS Institute) and SUDAAN (version 11 RTI International). T-tests were used to determine differences among groups, with p<0.05 considered statistically significant. Census Bureau region, §§ urbanicity, ¶¶ age group, annual household income, and health insurance status. †† Differences in ≥1-dose COVID-19 vaccination coverage were assessed by race and ethnicity and stratified by U.S.

The Kaplan-Meier survival analysis procedure was used, with vaccination month as the time-to-event variable, to estimate the cumulative percentage of persons vaccinated by the end of each month during December 2020–November 2021. Monthly survey response rates ranged from 17.2% to 23.4% (average = 20.6%).**

First-dose vaccination month and year were imputed for 4.9% of persons who reported they received vaccination but did not report their month and year of vaccination, using hot deck imputation (replacing missing values with observed values from a respondent with similar characteristics) from donor pools matched for month of interview, age group, region, and race and ethnicity. † Survey respondents who reported their race and ethnicity § and whether they received ≥1 dose of COVID-19 vaccine ¶ (516,190) during April 22–December 31, 2021, were included race and ethnicity was reported for 97.1% of respondents. adult population and calibrated to state-level vaccine administration data reported to CDC. territories.* Data are weighted to represent the noninstitutionalized U.S. NIS-ACM is a random-digit–dialed cellular telephone survey of adults aged ≥18 years in all 50 states, the District of Columbia, and selected local areas and U.S. Tailored efforts including community partnerships and trusted sources of information could be used to increase vaccination coverage among the groups with identified persistent disparities and can help achieve vaccination equity and prevent new disparities by race and ethnicity in booster dose coverage. Booster doses of COVID-19 vaccine are now recommended for all adults ( 4), but disparities in booster dose coverage among the fully vaccinated have become apparent ( 5). By the end of November 2021, national ≥1-dose COVID-19 vaccination coverage was similar for Black (78.2%), Hispanic (81.3%), NH/OPI (75.7%), and White adults (78.7%) however, coverage remained lower for AI/AN (61.8%) and multiple or other race (68.0%) adults. Asian and non-Hispanic White (White) adults had the highest ≥1-dose COVID-19 vaccination coverage by the end of April 2021 (69.6% and 59.0%, respectively) ≥1-dose coverage was lower among Hispanic (47.3%), non-Hispanic Black or African American (Black) (46.3%), Native Hawaiian or other Pacific Islander (NH/OPI) (45.9%), multiple or other race (42.6%), and American Indian or Alaska Native (AI/AN) (38.7%) adults.

adults during December 2020–November 2021. CDC analyzed data from the National Immunization Survey Adult COVID Module (NIS-ACM), a random-digit–dialed cellular telephone survey of adults aged ≥18 years, to assess disparities in COVID-19 vaccination coverage by race and ethnicity among U.S. Vaccination is highly effective in preventing severe COVID-19 illness and death ( 3), and equitable vaccination can reduce COVID-19–related disparities. Some racial and ethnic minority groups have experienced disproportionately higher rates of COVID-19–related illness and mortality ( 1, 2).

States percentage vaccinated